Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Kubo, H., et al
The longest published human trial on 5-Amino-1MQ followed participants for 12 weeks, with the study conducted at the University of Copenhagen and published in 2024
TA1 is approved in several countries for treating viral infections and has been used as an adjunct therapy in cancer and chronic hepatitis
After initial results, many researchers maintain lower frequency protocols rather than stopping entirely
doi: 10.1016/S0924-8579(99)00050-3 225 IsolauriEKirjavainenPSalminenS
J., Johnson, R
US$ 28.18
US$ 23.97
US$ 24.19
US$ 20.61
US$ 21.23
